Oh, Jiwon
O'Connor, Paul W.
Article History
First Online: 13 January 2015
Competing interests
: J.O. has received research funding from Genzyme and has received personal compensation for consulting or speaking from Biogen Idec, EMD Serono, Genzyme and Novartis. P.W.O. has received consulting fees and/or grant support from Actelion, Bayer, Biogen Idec, EMD Serono, Genentech, Novartis, Receptos, Roche, Sanofi–Genzyme and Teva.